Menu
ncarol.com
  • Home
  • Health
  • Real Estate
  • Business
  • Non-profit
  • Transportation
  • Education
  • Technology
  • Beauty
ncarol.com

GT Medical Technologies Wins Prestigious Innovator of the Year Award at the 2021 Governor's Celebration of Innovation
ncarol.com/10140205

Trending...
  • Tens of Thousands Complete Course to Master Entire Bible, Including Revelation
  • Kaltra Offers Microchannel Condensers Optimized for Low-GWP Refrigerants R454B, R32, and R290
  • Putting Your Roses to Bed for Winter in the Deep South - A Gentleman's Guide to Fall Rose Care
Matthew Likens, President & CEO GT Medical Technologies
Presented by Arizona Technology Council and Arizona Commerce Authority, Annual Event Celebrates the Visionaries Making Critical Contributions to Technology in Arizona

PHOENIX - ncarol.com -- GT Medical Technologies, Inc. today announced it was named a winner of the Innovator of the Year in the small company category at the 2021 Governor's Celebration of Innovation, presented live on stage by the Arizona Technology Council and the Arizona Commerce Authority on October 13. GT Medical Technologies received this accolade in recognition of GammaTile® Therapy, its Surgically Targeted Radiation Therapy (STaRT), developed to prevent or significantly delay the recurrence of operable brain tumors.

"We are honored to receive recognition for this innovative technology that overcomes the limitations of current brain tumor radiation treatments, raises the standard of care, and improves quality of life," said Matthew E. Likens, president, and CEO of GT Medical Technologies, Inc. "Since beginning full market release of GammaTile Therapy in the U.S. in March, 2020, over 50 major brain tumor treatment centers have adopted GT with many more in the pipeline. There have been few improvements in outcomes for these patients over the last 15 years so GT represents a major step forward."

More on ncarol.com
  • UV Weathering Test Chamber vs Xenon Arc Test Chamber: What's the Right Solution for Your Products
  • Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
  • Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
  • 2026 Oscars Betting Odds: One Battle After Another Favored for Best Picture
  • Allen Field Co., Inc. Components Selected for Esko ArtiosCAD 3D Component Library

Arizona's finest business leaders celebrate the state's technology innovation and leadership during GCOI. GT Medical Technologies was selected by judges for the company's numerous achievements, including  FDA 510(k) regulatory clearance for the treatment of all types of recurrent brain tumors and newly-diagnosed malignant tumors, and multicenter, randomized controlled trials such as one led by The University of Texas MD Anderson Cancer Center.

"We live in a world filled with innovative medical technology that is helping us take care of ourselves and improve our longevity," said Steven G. Zylstra, president and CEO of the Arizona Technology Council. "GT Medical Technologies is an example of an outstanding company based in Arizona that is contributing tremendous value to the MedTech industry. We congratulate the leadership and entire team for winning this well-deserved award."

About GT Medical Technologies, Inc.

More on ncarol.com
  • The International Window Coverings Expo Returns to Raleigh, NC April 21–23, 2026
  • Thirteen Reasons Why Gyminny Kids Is San Diego's Best Gymnastics Gym
  • Make Holiday Travel Easier with Carbon Fiber Belts from NoNickel
  • Heritage At Manalapan - A New Luxury Single Family Home Community Coming Late 2025
  • North Carolina Constitutional Economist Earns 4-Star Book Review from Literary Titan

Driven to overcome the limitations of current treatments for brain tumors and raise the standard of care, a team of brain tumor specialists joined forces and formed GT Medical Technologies with the purpose of improving the lives of patients with brain tumors. GammaTile is available in top brain tumor centers across the United States. For more information or to find a GammaTile center near you, visit https://www.gtmedtech.com/ and follow @GTMedTech on Twitter and LinkedIn.

Contact
GT Medical Technologies
***@brodeur.com


Source: Brodeur Partners
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Webinar Announcement: Reputational Risk Management in Internal Investigations: Controlling the Narrative Before, During, and After a Crisis
  • Taking on the Multi-Billion-Dollar Swipe Industry: AI Curates Who You Meet—IRL over brunch
  • BillyGoat Mulching Introduces Advanced Subsoil Mulching for Premium Land Finishing and Development
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
  • Vet Maps Launches National Platform to Spotlight Veteran-Owned Businesses and Causes
  • $114.6 Million in Revenues, Up 54%: Uni-Fuels Holdings (N A S D A Q: UFG) Accelerates Global Expansion Across Major Shipping Hubs as Demand Surges
  • Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
  • TradingHabits.com Launches to Support Day Trader Well-being
  • $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
  • $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
  • BITE Data raises $3m to build AI tools for global trade compliance teams
  • Phinge Issues Notice of Possible Infringement, Investigates App-less AI Agents & Technology for Unauthorized Use of its Patented App-less Technologies
  • Huntington Learning Center of Russellville Marks 1 Year Anniversary; Extends Reduced Grant-Aligned Rates to All Students in Learning Center Services
  • CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress
  • purelyIV Expands Wellness Services with Flu/COVID Testing and Menopause Coaching & Treatment
  • Perfume Making Kit: Professional Fragrance Creation Gift
  • WHES Retains BloombergNEF Tier 1 Ranking for Sixth Consecutive Quarter
  • U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
  • UK Financial Ltd Confirms All 8 Mexican Gold Mines Exist — Audited and Backing UKFL's Ecosystem With Double the 2018 Gold Value
_catLbl0 _catLbl1

Popular on ncarol.com

  • J French's #1 Album "I Don't Believe in Bad Days" Enters the Grammy Conversation - 161
  • Heritage at South Brunswick's Townhome Models Coming Soon! - 149
  • Arc Longevity Sells Out Debut Women's Creatine Gummy - 147
  • $300 Million Web3 Initiative and ZIGChain Partnership Power $20 Target in Noble Capital Markets Report for SEGG Media (N A S D A Q: SEGG) - 140
  • Preston Dermatology & Skin Surgery Center and Dr. Sheel Desai Solomon Dominate Raleigh's Best Awards from The News & Observer - 137
  • $430 Million 2026 Revenue Forecast; 26% Organic Growth; $500,000 Stock Dividend Highlight a Powerful AI & Digital Transformation Story: IQSTEL $IQST - 136
  • Mysterious Interstellar Object 3I/ATLAS Appears to Pause Near Mars, Exhibiting Periodic Light Pulses - 135
  • Mature Athlete - Want Elite, Web-Based Nutrition and Training Coaching? - 134
  • Maisano Brothers Inc. Expands National Paving Division Into Tampa, Florida - 129
  • New Free Educational Bingo Cards Make Learning English Fun for First Graders - 128

Similar on ncarol.com

  • Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
  • Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
  • November is Lung Cancer Awareness Month: Screening Saves Aims to Increase Access to Lung Screenings in NC
  • Valeo Health Leads a New Era of Longevity and Preventive Health in the UAE
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Cartwheel Signs Letter of Intent to License Clearsight Therapeutics' Novel Pink Eye Treatment for 2027 Portfolio Expansion
  • Dental Care Solutions Unveils New Website for Enhanced Patient Engagement
  • TradingHabits.com Launches to Support Day Trader Well-being
  • $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
  • $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute